611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line
1-877-756-4090

NurseWise 24-Hour Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

NurseWise 24-Hr Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Medical Disorders
Resources
Basic InformationLookupsLatest News
AHA: 3 Things to Know About CholesterolMajor Injuries Take a Toll on Mental HealthSome Activity Fine for Kids Recovering From Concussions, Docs SayArm Yourself Against the Coming Flu SeasonNew Cholesterol Guidelines Focus on Personalized ApproachChange Within the Eye May Be Early Warning for Macular DegenerationDead End for Treatment of Polio-Like Disorder Striking KidsNew Ebola Test Produces Results in Remote AreasHealth Tip: Symptoms of Kidney StonesHealth Tip: Warning Signs of Carpal Tunnel SyndromeTennis Elbow 'Treatments' Bring Little Relief: StudyHealth Tip: Keep Toxins from Your HomeSmoking, Diabetes May Be Especially Risky for Women's HeartsBlood Test May One Day Help Track Concussion RecoveryYour Showerhead May Be Bathing You in GermsWorst Bedsores Still Plague U.S. Hospital Patients: StudyHealth Tip: Use Petroleum Jelly to Protect Your SkinHome Health-Care Tests: Proceed With CautionSmartphones, Summer Birth Could Raise Kids' Odds for NearsightednessHigh Blood Pressure in Young Adults Tied to Earlier StrokesOver 2 Million Americans Have Hepatitis C; Opioids Help Drive SpreadHealth Tip: Tracking High TriglyceridesHealth Tip: Understanding Autoimmune DisordersFewer Late-Stage Kidney Deaths After Obamacare: StudySleep May Speed Kids' Recovery From ConcussionInstant-Soup Burns Send Almost 10,000 Kids to ERs Each YearParkinson's Patients Can Have a Normal Life SpanHospital Infections in Stroke Patients Raise Other RisksU.S. Hospitals Making Headway Against InfectionsAHA: Can You Really Be Scared to Death?Three Paralyzed Patients Now Walk, Thanks to Breakthrough TechnologyCould the Appendix Be Key to Parkinson's Disease?Trying to Get the New Shingles Vaccine? Join the CrowdEbola Vaccines Show Lasting EffectHealth Tip: Help Prevent a Sore ThroatBuilding Tolerance Helps Kids With Wheat AllergyGun Violence Among U.S. Youth Has High Price TagHealth Tip: Understanding MigrainesIs the U.S. Throwing Away Too Many Donor Kidneys?AHA: Can Daylight Saving Time Hurt the Heart? Prepare Now for SpringHealth Tip: Botox Isn't Just for WrinklesHealth Tip: Understanding Cataract SymptomsObese Patients Often Denied Kidney Transplants. Should They Be?New Research Offers Insights Into Football-Related ConcussionsAn Expert's Guide to Avoiding Back PainGene Therapy for Parkinson's Symptoms Shows PromiseDon't Blame Just Air Pollution for Asthma in KidsDoes Stroke Run in Your Family? Healthy Living Lowers the RiskCold, Windy Days Can Strain the HeartWhat Is the Virus That Has Killed 7 Children in New Jersey?
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Serum Caffeine, Metabolites May Predict Early Parkinson's Disease


HealthDay News
Updated: Jan 3rd 2018

new article illustration

WEDNESDAY, Jan. 3, 2018 (HealthDay News) -- Serum levels of caffeine and its metabolites could be diagnostic biomarkers for early Parkinson's disease (PD), according to a study published online Jan. 3 in Neurology.

Motoki Fujimaki, M.D., from the Juntendo University School of Medicine in Tokyo, and colleagues examined the kinetics and metabolism of caffeine in serum from 108 patients with PD and 31 age-matched healthy controls. Levels of caffeine and its 11 metabolites were examined by liquid chromatography-mass spectrometry. Direct sequencing was conducted to screen for mutations in caffeine-associated genes.

The researchers observed significant decreases in serum levels of caffeine and nine of its downstream metabolites, even in patients with early PD, which were unrelated to total caffeine intake or severity of disease. Compared with controls, there were no significant variations in CYP1A2 or CYP2E1, encoding cytochrome P450 enzymes involved in metabolizing caffeine. Patients with PD with motor complications had significantly decreased caffeine concentrations compared to PD patients without motor complications. There were no correlations between disease severity and single nucleotide variants of the ADORA2A gene encoding adenosine 2A receptor. In receiver operating characteristic curve analysis, the profile of serum caffeine and metabolite levels was identified as a potential diagnostic biomarker.

"Absolute lower levels of caffeine and caffeine metabolite profiles are promising diagnostic biomarkers for early PD," the authors write. "This is consistent with the neuroprotective effect of caffeine previously revealed by epidemiologic and experimental studies."

One author disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)